Senior Women Web

Travelers from Countries with Widespread Sustained Transmission of COVID-19 Arriving in the US; CDC is Working to Implement After-travel Health Precautions and EPA Disinfectants for Use Against SARS-CoV-2

Written by

SeniorWomenWeb

in

, , , , , , , , , , ,

CDC ResourcesCDC Badge for Corona Virus

 

To slow the spread of coronavirus disease 2019 (COVID-19) into the United States, CDC is working with state and local public health partners to implement after-travel health precautions.

Depending on your travel history, you will be asked to stay home for a period of 14 days from the time you left an area with widespread or ongoing community spread (Level 3 Travel Health Notice).

Countries that have a Level 3 Travel Health Notice (widespread, ongoing transmission):

 

COVID-19 Health Alert: Coronavirus Disease 2019 (COVID-19). You have traveled to a country with an outbreak of COVID-19 and are at higher risk.

Download PDF versionpdf icon

Stay home for 14 days from the time you left an area with widespread, ongoing community spread (Level 3 Travel Health Notice countries) and practice social distancing.

Take these steps to monitor your health and practice social distancing:

  1. Take your temperature with a thermometer two times a day and monitor for fever. Also watch for cough or trouble breathing.
  2. Stay home and avoid contact with others. Do not go to work or school for this 14-day period. Discuss your work situation with your employer before returning to work.
  3. Do not take public transportation, taxis, or ride-shares during the time you are practicing social distancing.
  4. Avoid crowded places (such as shopping centers and movie theaters) and limit your activities in public.
  5. Keep your distance from others (about 6 feet or 2 meters).

What To Do If You Get Sick

If you get sick with fever (100.4°F/38°C or higher), cough, or have trouble breathing:

  • Seek medical care. Call ahead before you go to a doctor’s office or emergency room.
  • Tell your doctor about your recent travel and your symptoms.
  • Avoid contact with others.

If you need to seek medical care for other reasons, such as dialysis, call ahead to your doctor and tell them about your recent travel to an area with widespread or ongoing community spread of COVID-19.

For additional questions on monitoring your health, contact your local public health officials pdf icon[2 pages]. 

List N: Disinfectants for Use Against SARS-CoV-2

The EPA-registered disinfectant products on our Disinfectants for Use Against SARS-CoV-2 list have qualified under EPA’s emerging viral pathogen program for use against SARS-CoV-2, a coronavirus that causes COVID-19. Coronaviruses are enveloped viruses, meaning they are one of the easiest types of viruses to kill with the appropriate disinfectant product. The emerging viral pathogen guidance was triggered for SARS-CoV-2 on January 29, 2020.   

EPA strongly recommends following the product label use directions for enveloped viruses, as indicated by the approved emerging viral pathogen claim on the master label. If the directions for use for viruses/virucidal activity list different contact times or dilutions, use the longest contact time or most concentrated solution.

Application Information for Registrants Wanting an Emerging Viral Pathogen Claim

A company can apply for an emerging viral pathogens claim, even before an outbreak occurs, based on previously EPA-approved claims for harder-to-kill viruses. EPA reviews the supporting information and determines if the claim is acceptable. Once approved, a company can make certain off-label claims as specified in the policy in the event of an outbreak such as the SARS-CoV-2. For instance, the company can include an efficacy statement on:

  • technical literature distributed to health care facilities, physicians, nurses, public health officials;
  • non-label-related websites;
  • consumer information services; and
  • social media sites.

Companies with EPA-registered disinfectants that want their products added to List N, should provide the information as outlined below to disinfectantslist (disinfectantslist@epa.gov).

  1. Ensure that the product has a previously approved emerging viral pathogen claim.
  2. Provide the product name and EPA Registration number.

Note: There may be additional disinfectants that meet the criteria for use against SARS-CoV-2. EPA will update this list with additional products as needed.

You may need a PDF reader to view some of the files on this page. See EPA’s About PDF page to learn more.

 

Comments

Leave a Reply

More posts